Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Can J Gastroenterol

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    December 2011
  1. TABRY H , Farrands PA
    Update on anal fistulae: surgical perspectives for the gastroenterologist.
    Can J Gastroenterol. 2011;25:675-80.
    PubMed     Text format     Related articles    Abstract available



  2. SOKOLLIK C , Ang M, Jones N
    Autophagy: a primer for the gastroenterologist/hepatologist.
    Can J Gastroenterol. 2011;25:667-74.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  3. JONES J , Panaccione R, Russell ML, Hilsden R, et al
    Medical management of inflammatory bowel disease among Canadian gastroenterologists.
    Can J Gastroenterol. 2011;25:565-9.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  4. QIN X
    What made Canada become a country with the highest incidence of inflammatory bowel disease: Could sucralose be the culprit?
    Can J Gastroenterol. 2011;25:511.
    PubMed     Text format     Related articles   



  5. LOOMES DE , Teshima C, Jacobs P, Fedorak RN, et al
    Health care resource use and costs in Crohn's disease before and after infliximab therapy.
    Can J Gastroenterol. 2011;25:497-502.
    PubMed     Text format     Related articles    Abstract available



  6. BINION DG , Louis E, Oldenburg B, Mulani P, et al
    Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis.
    Can J Gastroenterol. 2011;25:492-6.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  7. PANACCIONE R , Loftus EV Jr, Binion D, McHugh K, et al
    Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.
    Can J Gastroenterol. 2011;25:419-25.
    PubMed     Text format     Related articles    Abstract available



  8. COTE-DAIGNEAULT J , Bernard EJ
    Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review.
    Can J Gastroenterol. 2011;25:417-8.
    PubMed     Text format     Related articles   



  9. GHOSH S
    Estimating benefits of therapy in Crohn's disease in terms of indirect costs.
    Can J Gastroenterol. 2011;25:412.
    PubMed     Text format     Related articles   



    July 2011
  10. SCHICHO R , Storr M
    Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.
    Can J Gastroenterol. 2011;25:377-83.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  11. KUENSTNER JT
    Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: Controversy resolution requires the patient perspective, not the clinician perspective.
    Can J Gastroenterol. 2011;25:297-8.
    PubMed     Text format     Related articles   



    May 2011
  12. BERNSTEIN CN , El-Gabalawy H, Sargent M, Landers C, et al
    Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.
    Can J Gastroenterol. 2011;25:269-73.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  13. BOROWIEC AM , Fedorak RN
    Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.
    Can J Gastroenterol. 2011;25:140-6.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  14. MANGAT BK , Evaschen C, Lee T, Yoshida EM, et al
    Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia.
    Can J Gastroenterol. 2011;25:73-7.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  15. PROMISLOW S , Walker JR, Taheri M, Bernstein CN, et al
    How well does the Internet answer patients' questions about inflammatory bowel disease?
    Can J Gastroenterol. 2010;24:671-7.
    PubMed     Text format     Related articles    Abstract available



  16. FEDORAK RN , Wong K, Bridges R
    Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact.
    Can J Gastroenterol. 2010;24:651-5.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  17. ROSENFELD G , Bressler B
    Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective.
    Can J Gastroenterol. 2010;24:619-24.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  18. STEINHART AH , Tolomiczenko G
    IBD 2009: emerging research frontiers on the path to a cure.
    Can J Gastroenterol. 2010;24:557-65.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  19. DUCHARME J , Pelletier C, Zacharias R
    The safety of infliximab infusions in the community setting.
    Can J Gastroenterol. 2010;24:307-11.
    PubMed     Text format     Related articles    Abstract available



  20. COTTERILL L , Payne D, Levinson S, McLaughlin J, et al
    Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease.
    Can J Gastroenterol. 2010;24:297-302.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  21. IACUCCI M , de Silva S, Ghosh S
    Mesalazine in inflammatory bowel disease: A trendy topic once again?
    Can J Gastroenterol. 2010;24:127-33.
    PubMed     Text format     Related articles    Abstract available



  22. NARULA N , Yamamura DL, Marshall JK
    Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?
    Can J Gastroenterol. 2010;24:121-5.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  23. FREEMAN HJ , Maguire J
    Sellar inflammatory mass with inflammatory bowel disease.
    Can J Gastroenterol. 2010;24:58-60.
    PubMed     Text format     Related articles    Abstract available



  24. MONCRIEF KJ , Savu A, Ma MM, Bain VG, et al
    The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation - a single-centre experience.
    Can J Gastroenterol. 2010;24:40-6.
    PubMed     Text format     Related articles    Abstract available



    December 2009
  25. HOFMANN A , Beaulieu Y, Bernard F, Rico P, et al
    Fulminant legionellosis in two patients treated with infliximab for Crohn's disease: case series and literature review.
    Can J Gastroenterol. 2009;23:829-33.
    PubMed     Text format     Related articles    Abstract available



  26. DUPUIS M , Marshall JK, Hayes SM, Cytryn K, et al
    Assessing the educational needs of Canadian gastroenterologists and gastroenterology nurses: challenges to optimal care in Crohn's Disease.
    Can J Gastroenterol. 2009;23:805-10.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: